Bosch-Driessen LH et al. |
A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. |
2002 |
Am. J. Ophthalmol. |
pmid:12095805
|
Katusic D et al. |
Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. |
2003 |
Am. J. Ophthalmol. |
pmid:12654359
|
Fan LC et al. |
Macrolides protect against infection via inhibition of inflammasomes. |
2017 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:28684545
|
Shinkai M et al. |
Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. |
2006 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:16085674
|
Blau H et al. |
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. |
2007 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:17012372
|
Tarran R et al. |
Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion. |
2013 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:23542952
|
Kadova Z et al. |
IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. |
2015 |
Am. J. Physiol. Renal Physiol. |
pmid:25503728
|
Meyer M et al. |
Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. |
2009 |
Am. J. Respir. Cell Mol. Biol. |
pmid:19244203
|
Halldorsson S et al. |
Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:19372247
|
Bergamini G et al. |
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. |
2009 |
Am. J. Respir. Cell Mol. Biol. |
pmid:19097986
|
Kanazawa S et al. |
Azithromycin and bronchiolitis obliterans. |
2004 |
Am. J. Respir. Crit. Care Med. |
pmid:14982826
|
Tsai WC et al. |
Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. |
2004 |
Am. J. Respir. Crit. Care Med. |
pmid:15361366
|
Jeong BH et al. |
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. |
2015 |
Am. J. Respir. Crit. Care Med. |
pmid:25393520
|
Restrepo MI and Anzueto A |
Reply: Azithromycin: We're there! |
2014 |
Am. J. Respir. Crit. Care Med. |
pmid:25360733
|
Albert RK et al. |
Azithromycin: We're there! |
2014 |
Am. J. Respir. Crit. Care Med. |
pmid:25360732
|
Verleden GM et al. |
Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. |
2006 |
Am. J. Respir. Crit. Care Med. |
pmid:16741151
|
Barker PM et al. |
Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. |
2005 |
Am. J. Respir. Crit. Care Med. |
pmid:15657462
|
Choi GE et al. |
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. |
2012 |
Am. J. Respir. Crit. Care Med. |
pmid:22878281
|
Binder AM et al. |
Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. |
2013 |
Am. J. Respir. Crit. Care Med. |
pmid:23927602
|
Angel LF et al. |
Azithromycin in bronchiolitis obliterans: is the evidence strong enough? |
2006 |
Am. J. Respir. Crit. Care Med. |
pmid:16467178
|